Clinical Trials Logo

Attention Deficit Disorder clinical trials

View clinical trials related to Attention Deficit Disorder.

Filter by:

NCT ID: NCT06248229 Not yet recruiting - Fatigue Clinical Trials

A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

Start date: May 1, 2024
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to study the impact of Dyanavel on co-occuring fatigue in adults with Attention Deficit/Hyperactivity Disorder. The main question it aims to answer is whether Dyanavel XR leads to a statistically significant reduction in fatigue compared to placebo, as measured by the Fatigue Symptom Inventory.

NCT ID: NCT06194162 Recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Weighted Blankets for Sleep Disturbance Among Children With ADHD

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

Many children with ADHD suffer from sleep disorders and dysfunction, which may affect development and well-being. According to the clinicians, some children find relief from restlessness and difficulty sleeping by using weighted blankets which have been proposed to reduce restlessness and stress via sensory integration and to calm the child by stimulating the sense of touch, muscles and joints. However, evidence for an effect on sleep is scarce, and only one RCT has investigated the effect of weighted blankets among children with ADHD. Using a RCT design, the aim is to investigate the effect on sleep disorders and dysfunction in children with ADHD aged 5-12 years by (1) using a weighted blanket during night and daytime in addition to usual treatment, compared to (2) usual treatment and a non-weighted sham blanket, with the primary outcome being differences in total sleep time. Results will support health- and social professionals who are involved in the treatment of children with ADHD.

NCT ID: NCT06064942 Completed - Clinical trials for Attention-deficit/Hyperactivity Disorder

Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder

MFNT-CADHD
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to develop and to implement a multiple family narrative therapy intervention consisting of parent-child relationships training among Chinese families of children with attention deficit hyperactivity disorder (ADHD). The intervention aims to reduce the psychological distress of parents and their child, thus improving parent-child relationships, and the trial aims to assess the effectiveness of MFNT among them. A RCT design supplemented by qualitative interviews will be used to evaluate the effectiveness of multiple family narrative therapy intervention on family welfare.

NCT ID: NCT06030024 Completed - ADHD Clinical Trials

Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The purpose of the current open-lable study was to use low-frequency repetitive transcranial magnetic stimulation (rTMS) to improve the attention deficits in a sample of adult patients suffering from attention deficit disorder. Participants received 10 sessions of rTMS over Fz (located using the EEG 10-20 international system) and underwent assessments of their attentional capacity using the gradCPT task in an fMRI scanner, before and after the intervention. Other behavioral assessments of their attention symptoms have also been conducted.

NCT ID: NCT05793216 Active, not recruiting - Clinical trials for Educational Problems

VestibulOTherapy: Vestibular Impact on Learning

Start date: March 7, 2023
Phase: N/A
Study type: Interventional

Research Question: Will daily engagement in activities tailored to the evidence-based vestibular research result in improved attention and learning outcomes for children ages 6-9 years of age after an 8-week classroom-based intervention?

NCT ID: NCT05736458 Terminated - Clinical trials for Attention Deficit Hyperactivity Disorder

Network Control TMS fMRI

Start date: March 25, 2019
Phase: N/A
Study type: Interventional

This study uses different types of functional magnetic resonance imagining (fMRI) to generate individual transcranial magnetic stimulation (TMS) targets. During the TMS/fMRI imagining sessions, the investigators stimulate a target of either high or low regional controllability during a working memory task to investigate network responses and the impact of TMS on behavior.

NCT ID: NCT05406414 Recruiting - Depression Clinical Trials

The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems

Start date: May 23, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effect of a non-pharmacological transdiagnostic sleep intervention as add on to standard treatment for bipolar disorder, depression and attention deficit disorder. Our hypothesis is that the intervention will reduce the severity of the sleep problem and increase sleep quality compared to a control group receiving sleep hygiene education.

NCT ID: NCT05354232 Recruiting - Clinical trials for Attention Deficit Disorder With Hyperactivity

Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The investigators are investigating whether home-based tDCS over the course of four weeks can improve ADHD symptom severity and improve dysexecutive functioning (cognitive control). Further, the investigators are investigating whether there is a dose-dependent response to tDCS.

NCT ID: NCT05243186 Recruiting - Clinical trials for Attention Deficit Disorder

Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill

Start date: October 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Randomized clinical trial in which individuals who have been diagnosed with ADHD and are regularly treated with Methylphenidate will be test for cognitive performance and will be randomly examined in the following four conditions: - While taking Methylphenidate and sitting at a desk - While taking Methylphenidate and walking on a treadmill workstation - Without taking Methylphenidate while sitting at a desk - Without taking Methylphenidate while walking on a treadmill workstation The investigators will compare the cognitive achievements outcomes and evaluate the efficiency of studying in each of these four conditions.

NCT ID: NCT05200936 Completed - ADHD Clinical Trials

Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept Trial

Start date: December 17, 2021
Phase: Phase 2
Study type: Interventional

This study measures the safety and efficacy of repeated low dose MM-120 as treatment for ADHD in adults: a multi-center, randomized, double-blind, placebo-controlled